Try the newly designed PSNet website!Learn More
PSNet: Patient Safety Network
Journal Article

The randomized AMBORA trial: impact of pharmacological/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents.

Dürr P, Schlichtig K, Kelz C, et al. J Clin Oncol. 2021;Epub Apr 7.

Patients taking oral anti-cancer drugs may experience severe side effects and medication errors. In this randomized controlled study, patients taking oral chemotherapy drugs were randomized to receive usual care (control) or additional intensive pharmacological/pharmaceutical care (intervention). Patients in the intervention group reported considerably fewer medication errors and side effects and increased treatment satisfaction.